
72-patient multi-indication trial approved to fast track TRP-8803 commercialisation
Entropy Neurodynamics gets ethics approval for a Phase 1b/2a basket study of TRP-8803 across eight disorders, with 72 participants and first dosing expected this quarter.
पूरी खबर पढ़ें





















